Illumina engages in the development and manufacture of integrated systems for the analysis of genetic variation and function. It operates through the Core Illumina and Consolidated Variable Interest Entity segments (VIE). The Core Illumina segments serve customers in the research, clinical and applied markets, and enable the adoption of genomic solutions. The Consolidated VIE segment includes activities of GRAIL and Helix.... Show more
Segment: Core Illumina
Rating: Strong Buy
$59.52B

Market cap

Illumina Financial Health

Profitability:8.45/10

Illumina has better Profitability than 87.5% of the companies on the Medical Instruments & Equipment industry

Net Margin: 19.98%

Illumina has better Net Margin than 87.5% of the companies on the Medical Instruments & Equipment industry


ROE (Return on Equity): 0%

Illumina has better ROE (Return on Equity) than 100% of the companies on the Medical Instruments & Equipment industry


ROA (Return on Assets): 2.2%

Illumina has better ROA (Return on Assets) than 87.5% of the companies on the Medical Instruments & Equipment industry


Operating Efficiency:8.52/10

Illumina has better Operating Efficiency than 83.33% of the companies on the Medical Instruments & Equipment industry

Operating Margin: 23.65%

Illumina has better Operating Margin than 83.33% of the companies on the Medical Instruments & Equipment industry


Liquidity:8.78/10

Illumina has better Liquidity than 75% of the companies on the Medical Instruments & Equipment industry

Quick Ratio: 3.51

Illumina has better Quick Ratio than 62.5% of the companies on the Medical Instruments & Equipment industry


Operating Cash Flow Ratio: 0.84

Illumina has better Operating Cash Flow Ratio than 87.5% of the companies on the Medical Instruments & Equipment industry


Solvency:8.63/10

Illumina has better Solvency than 87.5% of the companies on the Medical Instruments & Equipment industry

Debt to Equity Ratio: 0.25

Illumina has better Debt to Equity Ratio than 100% of the companies on the Medical Instruments & Equipment industry


Interest Coverage Ratio: 0.84

Illumina has better Interest Coverage Ratio than 87.5% of the companies on the Medical Instruments & Equipment industry


Illumina revenue quarter by quarter
Illumina operating expenses

👀 Get a summary of every week for free

Top company news, earnings report, analysis and more.

InspectCompany.com

We aim to help investors learn more about the companies in which they invest. We believe investing should be less about trying to find patterns in charts and more about investing in the companies that better represent your vision for the future.

Disclaimer: InspectCompany does not guarantee that any of the information available on our website, APIs or provided by any other means is complete, accurate, current, reliable or appropriate for your needs. Some of our information is provided by third party services and we cannot guarantee that is complete, accurate, current, reliable or appropriate for your needs. The information and recommendations on this site are for educational purposes only and should not be used to replace the advice of financial advisors and other professionals. All our services, information, data and/or recommendations are provided on an "as is" basis and without warranties of any kind, either express or implied. We do not guarantee that our services, information, data and/or recommendations are complete, accurate, current, reliable or appropriate for your needs.  Read more